1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Dynamic Medical Technologies Inc.

Dynamic Medical Technologies Inc.

TTPEX:4138
54.00
TWD
-1.00
(-1.82%)
4.27EPS
13.96P/E
2.04BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
25.47
34.15
33.07
30.42
28.97
29.17
29.51
25.28
25.75
32.35
39.91
39.39
34.73
34.91
Basic EPS, GAAP
1.17
3.02
3.04
2.97
2.83
2.63
2.82
2.9
3.09
3.43
5.27
5.14
3.81
3.65
Free Cash Flow per Basic Share
4.36
11.03
5.06
5.79
3.01
3.28
5.89
6.01
5.89
4.06
7.24
3.17
6.58
6.98
Dividend per Share
3.19
1.13
2.64
2.73
2.67
2.55
2.37
2.52
2.63
2.78
2.37
5.58
3.77
- -
Book Value per Share
27.11
30.92
32.49
31.83
31.05
31.84
32.1
32.33
32.16
34.75
38.47
38.47
41.79
39.56
Tangible Book Value per Share
27.08
30.9
32.48
31.81
31.04
31.82
32.02
32.24
32.07
34.66
38.35
38.37
41.7
39.47
Basic Weighted Avg Shares
35
35
40
40
40
40
40
40
40
40
40
40
40
40
Sales/Revenue/Turnover
898
1,204
1,314
1,215
1,157
1,165
1,178
1,009
1,028
1,292
1,594
1,573
1,387
1,395
Operating Margin (%)
4.81
10.63
11.95
16.03
16.78
11.92
13.67
14.31
15.73
12.04
16.67
15.64
13.38
12.31
Depreciation Expense
50
53
44
34
37
36
65
80
96
115
149
178
150
143
Net Income, GAAP
41
106
121
118
113
105
113
116
123
137
210
205
152
146
Effective Tax Rate (%)
25.94
20.63
17.81
18.79
18.39
14.14
21.19
21.55
18.49
21.5
20.03
17.82
17.47
17.45
Profit Margin (%)
4.61
8.84
9.19
9.75
9.78
9.01
9.55
11.49
11.98
10.61
13.2
13.06
10.97
10.47
Working Capital
682
672
1,208
1,240
939
1,018
945
982
985
860
1,013
1,037
1,009
996
LT Debt
- -
- -
290
295
- -
- -
131
118
166
231
274
347
317
290
Total Equity
1,097
1,212
1,423
1,418
1,409
1,433
1,468
1,463
1,472
1,554
1,704
1,760
1,892
1,787
Return on Invested Capital (%)
2.29
7.65
8.69
9.12
9.15
7.19
7.97
6.68
7.85
6.95
10.52
9.14
6.94
6.63
Return on Capital (%)
3.65
8.1
7.92
5.4
5.09
5.6
6.5
7.12
6.39
7.69
9.27
8.18
5.72
5.88
Return on Common Equity (%)
4.29
10.32
10.12
9.22
9.01
8.36
8.81
9.02
9.57
10.26
14.39
13.37
9.49
9.57

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
90
93
93
LT Borrowings
- -
- -
- -
LT Finance Leases
317
312
290
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
40
40
40
Market Capitalization
2,404
2,424
2,036

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,879
1,944
1,847
Cash, Cash Equivalents & STI
1,302
1,315
1,194
Accounts Receivable, Net
212
296
300
Inventories
279
253
280
Total Current Liabilities
870
989
851
Payables & Accruals
- -
- -
- -
ST Debt
90
93
93
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.95%
5.33%
7.55%
Free Cash Flow
15.41%
19.34%
107.63%
Net Income, GAAP
3.92%
8.52%
-25.97%
Sales/Revenue/Turnover
1.29%
7.55%
-11.82%
Total Cash Common Dividend
9.5%
19.73%
-32.37%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
403
398
356
415
1,573
2025
351
327
338
370
1,387
2026
343
344
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.21
1.25
1.2
1.5
5.14
2025
1.04
0.94
0.91
0.92
3.81
2026
0.84
0.99
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5.58
2025
- -
- -
- -
- -
3.77
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kuo Lung Wu
Full Time Employees
85
Sector
Health technology
Industry
Medical specialties
Address
No. 880, Zhongzheng Road New Taipei TP Taiwan 23586
IPO Date
Dec 28, 2009
Website
dmttw.com.tw
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Dynamic Medical Technologies Inc. (4138.TWO) develops, manufactures, and markets medical devices focused on wound care and regenerative medicine. The company offers a portfolio of advanced biological products and systems, including VIAFLO cryopreserved human placental membrane allografts for wound closure; VIAFLO dermal allografts for soft tissue repair; and cryopreserved amniotic membrane products such as DynaMatrix and DynaGraft for surgical applications; as well as extracellular matrix (ECM) scaffolds like DynaMatrix extracellular membrane and DynaGraft dermal regeneration matrix. These products target chronic wounds, burns, surgical sites, and orthopedic applications, serving healthcare providers including hospitals, clinics, and ambulatory surgery centers primarily in Taiwan and select international markets. Founded in 2018 and headquartered in New Taipei City, Taiwan, the company operates within the medical technology sector, emphasizing regenerative tissue technologies derived from human placental and amniotic tissues sourced through proprietary processing methods. Dynamic Medical Technologies maintains a focused geographic footprint in Asia, with distribution partnerships extending to North America and Europe for global reach. In recent developments, the company expanded its product pipeline with the launch of new VIAFLO-series allografts in 2024, enhancing its offerings for diabetic foot ulcers and pressure injuries. It secured a strategic distribution alliance with a major U.S. wound care distributor in early 2025, boosting North American market penetration, and completed a secondary listing preparation on the Taiwan Stock Exchange, attracting institutional investment. Additionally, Dynamic Medical Technologies announced an acquisition of a complementary biotech firm specializing in ECM technologies in late 2024, strengthening its R&D capabilities and production capacity.